FDA Approved: POSACONAZOLE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a generic posaconazole product from Mylan Institutional LLC under an Original Application (ANDA 211500). The approval indicates the generic version…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• Posaconazole (generic) (Posaconazole)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)